https://deliveryplatformreview.com 2026-11-01T15:46:11.741Z daily 1 https://deliveryplatformreview.com/sections/nanomedicine-platforms 2026-11-01T15:46:11.741Z weekly 0.5 https://deliveryplatformreview.com/sections/drug-delivery 2026-10-27T14:52:11.043Z weekly 0.5 https://deliveryplatformreview.com/sections/glp-1-therapeutics 2026-10-22T13:37:01.276Z weekly 0.5 https://deliveryplatformreview.com/sections/intranasal-delivery 2026-10-04T15:10:15.848Z weekly 0.5 https://deliveryplatformreview.com/sections/translational-research 2026-10-14T13:46:59.149Z weekly 0.5 https://deliveryplatformreview.com/authors/daniel-ng 2026-11-01T15:46:11.741Z weekly 0.4 https://deliveryplatformreview.com/authors/priya-subramaniam 2026-11-01T15:46:11.741Z weekly 0.4 https://deliveryplatformreview.com/authors/cecilia-brandt-kowalski 2026-11-01T15:46:11.741Z weekly 0.4 https://deliveryplatformreview.com/authors/marcus-oyelaran 2026-11-01T15:46:11.741Z weekly 0.4 https://deliveryplatformreview.com/posts/tracing-polymer-nanoparticle-peptide-delivery-ownership-from-academic-filing-to https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/35d843b3-d923-4e36-8a11-7468ee9a6b7f.jpeg 2026-11-01T15:46:11.741Z monthly 0.7 https://deliveryplatformreview.com/posts/transneuronal-and-transcellular-transport-mechanisms-that-nanoparticle-formulati https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/e10a7d25-2610-4a3a-af6f-554a4f898869.jpeg 2026-10-29T14:06:24.516Z monthly 0.7 https://deliveryplatformreview.com/posts/academic-peptide-nanoparticle-patent-portfolios-evaluated-by-platform-architectu https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/d94028cb-4ded-4570-a018-711bd1646ef6.jpeg 2026-10-28T15:31:56.061Z monthly 0.7 https://deliveryplatformreview.com/posts/nasal-mucosal-absorption-mechanics-and-why-intranasal-glp-1-outpaces-oral-bioava https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/90520b91-89ca-44c5-88fb-937d98846088.jpeg 2026-10-27T14:52:11.043Z monthly 0.7 https://deliveryplatformreview.com/posts/nose-to-brain-nanoparticle-platform-differentiation-across-reward-circuit-and-de https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/f68db8a7-3e27-431b-8f57-79160ec5b3ba.jpeg 2026-10-26T14:40:55.455Z monthly 0.7 https://deliveryplatformreview.com/posts/intranasal-nanoparticle-platform-developers-advancing-peptide-cns-indications-fr https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/0dfe4104-1a28-4fba-8b65-86b5516b8289.jpeg 2026-10-25T14:21:17.721Z monthly 0.7 https://deliveryplatformreview.com/posts/benchmarking-university-spinout-ip-estates-across-nanoparticle-peptide-delivery https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/337a5700-aba0-4b00-ac0a-e155778bf2ac.jpeg 2026-10-24T14:21:06.213Z monthly 0.7 https://deliveryplatformreview.com/posts/injection-anxiety-and-dose-titration-failures-as-structural-drivers-of-early-glp https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/5dc6dd19-e279-4a9c-b959-076887d08cc5.jpeg 2026-10-22T13:37:01.276Z monthly 0.7 https://deliveryplatformreview.com/posts/pulmonary-inhalation-as-a-peptide-delivery-route-for-systemic-indications https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/4aecf6ba-4a63-406f-9477-2e6b74259de1.jpeg 2026-10-21T14:11:20.664Z monthly 0.7 https://deliveryplatformreview.com/posts/long-acting-peptide-depot-formulations-as-an-injection-reduction-strategy https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/5cc03095-692d-4e05-a049-7df6059a39e5.jpeg 2026-10-19T15:06:27.568Z monthly 0.7 https://deliveryplatformreview.com/posts/blood-brain-barrier-crossing-strategies-for-large-biologic-molecules https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/4739eb1a-e67f-4d61-99ec-4614f460d65d.jpeg 2026-10-18T14:30:51.785Z monthly 0.7 https://deliveryplatformreview.com/posts/peptide-absorption-enhancers-in-non-injectable-formulations https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/937d8af7-8759-4597-8507-75f1d90a550b.jpeg 2026-10-17T15:00:53.262Z monthly 0.7 https://deliveryplatformreview.com/posts/transdermal-peptide-delivery-technologies-and-their-glp-1-applicability https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/cf369dd0-d6fb-49b9-a857-1c1d55a27a78.png 2026-10-16T14:46:06.841Z monthly 0.7 https://deliveryplatformreview.com/posts/translating-academic-nanoparticle-ip-into-a-drug-development-program https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/60f897fd-d439-4e1e-b2fd-a7421c16b9e1.jpeg 2026-10-14T13:46:59.149Z monthly 0.7 https://deliveryplatformreview.com/posts/intellectual-property-landscape-of-nanoparticle-drug-delivery-patents https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/67c24629-2200-4d03-b3ee-5584d525aabe.jpeg 2026-10-10T15:26:15.872Z monthly 0.7 https://deliveryplatformreview.com/posts/nanoparticle-platforms-engineering-peptide-blood-brain-barrier-crossing https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/49c4179a-3256-4222-987b-a1f918c11401.png 2026-10-08T13:30:44.874Z monthly 0.7 https://deliveryplatformreview.com/posts/nanoparticle-scale-up-challenges-from-lab-bench-to-gmp-manufacturing https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/25a47147-f119-446d-864b-ea6a6988ae8d.png 2026-10-07T13:51:01.490Z monthly 0.7 https://deliveryplatformreview.com/posts/regulatory-pathway-for-intranasal-cns-drug-products-at-fda https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/3e8da195-6016-4d1e-9403-f34435c8f844.jpeg 2026-10-04T15:10:15.848Z monthly 0.7 https://deliveryplatformreview.com/posts/bioavailability-benchmarks-for-intranasal-peptide-formulations https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/61718ffc-2307-4069-a4ff-7ca6aee0b09d.jpeg 2026-10-03T15:34:42.008Z monthly 0.7 https://deliveryplatformreview.com/posts/nose-to-brain-delivery-for-cns-active-peptides-in-preclinical-models https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/3a61ec76-3578-415a-9eb6-93673fce185d.jpeg 2026-10-01T15:00:46.894Z monthly 0.7 https://deliveryplatformreview.com/posts/subcutaneous-auto-injector-design-and-its-adherence-ceiling https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/1bc72f9b-c3f4-4347-ba9f-a8cb9f134f32.jpeg 2026-09-30T17:47:15.157Z monthly 0.7 https://deliveryplatformreview.com/posts/oral-glp-1-delivery-platforms-and-the-bioavailability-problem https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/c604249c-a7b8-448c-b777-e21d32f0060f.jpeg 2026-09-30T16:51:52.736Z monthly 0.7 https://deliveryplatformreview.com/posts/weight-loss-versus-metabolic-benefit-in-glp-1-therapy https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/c5c47717-e000-439a-81e3-703a33c50c5f.jpeg 2026-09-30T16:07:17.658Z monthly 0.7 https://deliveryplatformreview.com/posts/glp-1-receptor-agonists-in-type-1-diabetes-and-non-obesity-indications https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/397ab0cd-4ca9-426d-b354-05e3581e9485.jpeg 2026-09-29T01:30:46.832Z monthly 0.7 https://deliveryplatformreview.com/posts/glp-1-receptor-distribution-in-the-brain-and-cns-pharmacology https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/6014a5d0-3c07-442c-9951-b44d81ea6ffc.jpeg 2026-09-26T04:55:46.536Z monthly 0.7 https://deliveryplatformreview.com/posts/peptide-stability-challenges-in-glp-1-analog-formulation https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/3840c23c-fc7e-4cc8-963e-51346800c71a.jpeg 2026-09-24T23:40:27.627Z monthly 0.7 https://deliveryplatformreview.com/posts/nausea-mechanisms-in-glp-1-therapy-and-formulation-solutions https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/2e7be6bf-2e2f-4a9d-b3f1-1793d8be87e9.jpeg 2026-09-21T15:16:51.048Z monthly 0.7 https://deliveryplatformreview.com/posts/glp-1-injectable-dropout-rates-and-the-compliance-crisis https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/f4145c56-35f5-4be8-984a-b119a380618d.jpeg 2026-09-18T14:35:33.973Z monthly 0.7 https://deliveryplatformreview.com/posts/lipid-nanoparticles-vs-polymeric-nanoparticles-for-delivering-peptides-to-the-cn https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/613e6ef8-3865-4389-8e69-931b1b451871/generated/178c2d6b-b231-491a-8660-3c963c4389d9.jpeg 2026-09-17T14:49:51.629Z monthly 0.7